Andy Kessler Quote
"There really isn't a business model for early detection, not yet. There is more of a negative for expensive pharmaceuticals and treatment centers, the day that heart disease, stroke and cancer begin to subside in numbers.
However, sometime in the next several years [around 2011], as the silicon and software and algorithms developed for early detection begin to get cheap enough, these business models will emerge, and you will see venture capitalists step up to fund interesting companies and IPOs of the hot new early detection players. 3-D imaging, computer aided detection, biomarkers, molecular imaging probes, nanotech scan devices for antibody chips, these are all areas that we will see companies emerge."